BCR (Common Stock)
Change (%)0.00 (0.00%)
Data provided by Nasdaq. Minimum 15 minutes delayed.
Bard Announces Third Quarter Results
Bard Declares Quarterly Dividend
C. R. Bard Receives FDA Premarket Approval of the LUTONIX® 035 Drug Coated Balloon as the First and Only DCB for the Treatment of Patients with Dysfunctional AV Fistulae
Bard Shareholders Approve Proposed Merger With Becton, Dickinson